Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration

Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration

Bibliographic Details
Main Author:	Di Zhang
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	The Journal of Clinical Hypertension
Online Access:	https://doi.org/10.1111/jch.14538

Similar Items

Hyperuricemia, gout and comorbidity
by: N. A. Shostak, et al.
Published: (2023-01-01)

DIET IN GOUT AND HYPERURICEMIA
by: O. V. Zhelyabina, et al.
Published: (2017-09-01)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
by: Fernando Pérez-Ruiz, et al.
Published: (2019-05-01)

Treatment of hyperuricemia, gout and other crystalline arthritidies
by: F. Lioté
Published: (2012-01-01)

FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS
by: M. S. Petrova, et al.
Published: (2017-11-01)

Susceptibility genes of hyperuricemia and gout
by: Yue-Li Nian, et al.
Published: (2022-08-01)

Gout, hyperuricemia and cardiovascular risk
by: A E Iljina, et al.
Published: (2009-02-01)

Gout, hyperuricemia and cardio-vascular risk
by: Laura Morbidoni, et al.
Published: (2018-06-01)

Mechanisms of cartilage damage in gout and hyperuricemia
by: E. V. Panina
Published: (2024-04-01)

NEW OPPORTUNITIES FOR CORRECTION OF HYPERURICEMIA IN GOUT
by: Svetlana Evgenyevna Myasoedova, et al.
Published: (2009-12-01)

Modifiable nutritional factors in hyperuricemia and gout
by: Olga A. Georginova, et al.
Published: (2022-11-01)

Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan
by: Masafumi Kurajoh, et al.
Published: (2024-01-01)

Why Does Hyperuricemia Not Necessarily Induce Gout?
by: Wei-Zheng Zhang
Published: (2021-02-01)

The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data
by: Seigo Akari, et al.
Published: (2022-08-01)

Epidemiological perspectives on emerging contaminants and gout or hyperuricemia
by: Weiwen Fu, et al.
Published: (2025-06-01)

Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
by: Ling Cao, et al.
Published: (2021-01-01)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
by: Xinghong Wu, et al.
Published: (2023-01-01)

COMORBIDITY AND GOUT: ASSOCIATION BETWEEN HYPERURICEMIA AND BLOOD PARAMETERS AS A PREDICTOR OF GOUT
by: Erna Islamagic, et al.
Published: (2020-04-01)

Editorial: Natural products in the treatment of Hyperuricemia, gout and other metabolic disorders
by: Ferid Abdulhafiz, et al.
Published: (2023-11-01)

Associations of metal exposure with hyperuricemia and gout in general adults
by: Jing Xu, et al.
Published: (2022-12-01)

Features of impact of hyperferritinemia in combination with hyperuricemia on the course of gout.
by: G. P. Kuzmina, et al.
Published: (2020-04-01)

Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
by: M. S. Eliseev, et al.
Published: (2024-10-01)

The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout
by: Xin-yu Fang, et al.
Published: (2022-06-01)

Biomimetic bioreactor for potentiated uricase replacement therapy in hyperuricemia and gout
by: Bin Yang, et al.
Published: (2025-01-01)

Awareness of Gout and Hyperuricemia in a Sample of the Adult Population in Iraq
by: Shaimaa Jubair, et al.
Published: (2022-06-01)

Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
by: Pengfei Liu, et al.
Published: (2024-10-01)

Hyperuricemia and gout: effects on bone and articular cartilage (literature review)
by: E. V. Cheremushkina, et al.
Published: (2023-01-01)

Prevalence of Chronic Kidney Disease and Hyperuricemia in Gout Arthritis Patients
by: Can Hüzmeli̇, et al.
Published: (2019-04-01)

Exploring RNA modifications, editing, and splicing changes in hyperuricemia and gout
by: Chung-Ming Huang, et al.
Published: (2022-09-01)

Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia
by: Lada Beara-Lasic, et al.
Published: (2010-02-01)

GOUT AND HYPERURICEMIA AS ADDITIONAL FACTORS OF DETERIORATION OF CARDIAC AND RENAL PATHOLOGIES
by: Snigurska I. O., et al.
Published: (2022-11-01)

Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01)

Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout
by: Shuaiwei Song, et al.
Published: (2024-07-01)

Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
by: V. I. Mazurov, et al.
Published: (2020-12-01)

NUMB dysfunction defines a novel mechanism underlying hyperuricemia and gout
by: Jingwei Chi, et al.
Published: (2024-10-01)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)

Association of oxidative balance score with hyperuricemia and gout: NHANES 2009-2018
by: Yiting He, et al.
Published: (2024-11-01)

Commentary: Gut microbiota reduce the risk of hyperuricemia and gout in the human body
by: Lin Wang, et al.
Published: (2024-01-01)

Hyperuricemia and Gout are Associated with the Risk of Atrial Fibrillation: An Updated Meta-Analysis
by: Yingjian Deng, et al.
Published: (2022-05-01)

Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
by: M S Eliseev, et al.
Published: (2019-05-01)